-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - /
10 sulindac/
11 (Aceclofenac or Acemetacin or "Acetylsalicylic acid" or Alclofenac or Aminopyrine … or Amodiaquine or Amoxiprin or Ampyrone or Antipyrine or Apazone or Aspirin or
C-2
Azapropazone … Tilidine or tonazocine or Tramadol or
trimeperidine)
3 TITLE-ABS-KEY(Aceclofenac or Acemetacin or "Acetylsalicylic … acid" or Alclofenac or
Aminopyrine or Amodiaquine or Amoxiprin or Ampyrone or Antipyrine or Apazone … or
Aspirin or Azapropazone or Benorilate or Benorylate or Bromelains or Bromfenac or
"BW-755C" or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
June 01, 2012 - Treatment
duration/
Study
period
Primary
outcome
Findings
63% treatment, a statin, and
aspirin … medical treatment
(antihypertensive
treatment, a statin, and
aspirin only); dose:NR;
(n=76)
Two … Primary
outcome
Findings
Age:66.5 yrs; Male:
63%
(antihypertensive
treatment, a statin, and
aspirin
-
effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
October 01, 2007 - adjust for 5 potential confounders not
measured in the administrative claims data (smoking, obesity,
aspirin … Demographics X X X
Diagnoses X X X
Procedures X X X
Prescriptions X X X
Visits X X X
Smoking — — X
Aspirin
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-222-evidence-summary-health-equity.pdf
January 01, 2020 - smoking cessation: behavioral and
pharmacotherapy interventionsb
Adults
Cardiovascular
disease
Aspirin … cancer
screening
0 0 0 0 1
Tobacco
smoking
cessation
0 3 1 2 0
Cardio-
vascular
disease
Aspirin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
January 01, 2020 - smoking cessation: behavioral and
pharmacotherapy interventionsb
Adults
Cardiovascular
disease
Aspirin … cancer
screening
0 0 0 0 1
Tobacco
smoking
cessation
0 3 1 2 0
Cardio-
vascular
disease
Aspirin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - is that venous thromboembolism
prophylaxis after total hip and knee replacement with
warfarin or aspirin … Use of
LMWH (compared with aspirin and mechanical device)
? … Prevention of pulmonary
embolism and deep vein thrombosis with low dose
aspirin. … The 2008 ACCP
guidelines gave a Grade 1A recommendation against
aspirin as TP for any patient group … and the 2010 UK
NICE guidelines do not include aspirin as TP for any
patient group.1,8 There are no
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
January 03, 2012 - For example, when Rietbrock
et al. considered the comparative effectiveness of
warfarin and aspirin … How effective are dose-adjusted warfarin and
aspirin for the prevention of stroke in patients
with
-
effectivehealthcare.ahrq.gov/products/coronary-stents-outcomes/research
February 10, 2010 - NS
Pre-Procedural Shock
3675 (1.7%)
1746 (3.9%)
<0.001
2.1
2.1
NS
Pre-Procedural Aspirin … Race, Hispanic
1.138
1.018
1.272
Race, Asian
1.206
1.037
1.401
Contraindication to Aspirin
-
effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - For example, evidence of the benefits of aspirin
for prevention of cardiovascular events from patients … patients with and without heart disease may be
useful for estimating the gastrointestinal risks of aspirin
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
January 01, 2011 - For example, evidence of the benefits of aspirin
for prevention of cardiovascular events from patients … patients with and without heart disease may be
useful for estimating the gastrointestinal risks of aspirin
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
March 01, 2017 - Nonsteroidal
Anti-
Inflammatory
Drugs (NSAIDs)
• No evidence was available for the effect of low-dose aspirin … on MCI or CATD incidence.
• Low-strength evidence shows no benefit for low-dose aspirin on brief cognitive
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
March 01, 2017 - Nonsteroidal
Anti-
Inflammatory
Drugs (NSAIDs)
• No evidence was available for the effect of low-dose aspirin … on MCI or CATD incidence.
• Low-strength evidence shows no benefit for low-dose aspirin on brief cognitive
-
effectivehealthcare.ahrq.gov/products/back-pain-treatment/research-protocol
October 08, 2014 - combinations thereof)
Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, celecoxib, acetylsalicylic … acid (aspirin)
Nonopioid analgesics, such as acetaminophen
Opioid analgesics, such as oxycodone,
-
effectivehealthcare.ahrq.gov/health-topics/premenstrual-syndrome
-
effectivehealthcare.ahrq.gov/health-topics/common-cold
-
effectivehealthcare.ahrq.gov/health-topics/reye-syndrome
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
August 01, 2016 - American adults are increasingly likely to be treated
with statins, antihypertensives, and low-dose aspirin … mass index, BP, diabetes, kidney disease, other
nutrients or supplements, and drugs (e.g., statins,
aspirin … No studies explicitly compared
the interaction of n-3 FA intake (or biomarker level) with
aspirin intake … mass
index, BP, diabetes, kidney disease, other nutrients or
supplements, and drugs (e.g., statins, aspirin … data may be confounded
by shifts over time in concomitant therapy to reduce CVD
risk (e.g., statins, aspirin
-
effectivehealthcare.ahrq.gov/health-topics/diabetic-heart-disease
-
effectivehealthcare.ahrq.gov/health-topics/blood-thinners/
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - For example, in an SR of aspirin use for
prevention of cardiovascular disease and colorectal cancer, … 40 NRSIs (and RCTs) were excluded
if they did not report on a comparison between aspirin and a non-aspirin … Aspirin Use to Prevent
Cardiovascular Disease and Colorectal
Cancer: An Evidence Update for the U.S